Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cara Therapeutics, Inc. - Common Stock
(NQ:
CARA
)
5.320
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cara Therapeutics, Inc. - Common Stock
< Previous
1
2
Next >
CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA
February 20, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA
January 06, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ARCH on Behalf of Shareholders
December 19, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
CARA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cara Therapeutics, Inc. Is Fair to Shareholders
December 18, 2024
From
Halper Sadeh LLC
Via
Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Cara Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
December 18, 2024
From
Ademi LLP
Via
Business Wire
Cara Therapeutics Announces Exploration of Strategic Alternatives
July 11, 2024
Piper Sandler & Co. to act as financial advisor
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
June 12, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Reports First Quarter 2024 Financial Results
May 13, 2024
Topline efficacy and safety results from KOURAGE 1 Part A portion of notalgia paresthetica (NP) pivotal program now expected by the end of 2Q24
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
May 06, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
March 07, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
March 04, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
February 12, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
January 22, 2024
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
December 18, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Reports Third Quarter 2023 Financial Results
November 13, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
November 02, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
October 23, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients
September 25, 2023
Approval triggers $1.5 million milestone payment to Cara
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Inc. (NASDAQ: CARA) Leading the Way in Friday Trading Based on Percentage Gain
September 15, 2023
Via
Investor Brand Network
Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Reports Second Quarter 2023 Financial Results
August 07, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors
August 03, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
July 24, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Present at the Jefferies Healthcare Conference
June 01, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus
May 18, 2023
Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in...
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Reports First Quarter 2023 Financial Results
May 15, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023
May 01, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
April 10, 2023
From
Cara Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
